Physicians Lab Inc.’s Post

A recent network meta-analysis titled "Effects of Different Treatment Measures on the Efficacy of Diabetic Foot Ulcers" explored a range of treatment options. Notably, the analysis highlighted that topical oxygen therapy (TOT) achieved higher ulcer healing rates compared to standard of care (SoC). This marks the 7th meta-analysis including data from a NATROX® O₂ randomized controlled trial (RCT), reinforcing the efficacy of TOT in advancing wound healing. Explore all seven TOT meta-analyses here: https://bit.ly/40u8rJX #DiabeticFootCare #WoundHealing #TopicalOxygenTherapy #NATROX

Understanding the “what” is valuable. Understanding the “why” is game-changing. Case in point: In recent research on systemic lupus erythematosus (SLE) patients in the U.S., unfiltered, HIPAA-compliant doctor’s notes revealed the exact reasons behind why an HCP prescribed antibiotics and reduced steroid use for a specific patient. No guesswork, no hypotheses—just real, actionable insights. Be in the room where it happens with Amplity Insights™, our proprietary database, for raw, rich, conversations between doctors and patients so your commercial teams can drive deeper engagement and better outcomes. Learn how Amplity Insights can be used across other disease states and therapeutic areas now! https://lnkd.in/g3xWfHn7 #lupus #qualitativedata #actionableinsights #providerengagement

A range of different #myositis specific and associated #autoantibodies have now been described. Very rare autoantibodies and those discovered within the last 5–10 years are typically not included in standard testing panels. When patients test ‘negative’ for myositis autoantibodies clinicians should consider whether extended testing for connective tissue disease overlap autoantibodies (e.g. U1RNP) could be of benefit in addition to extended spectrum autoantibody testing for rare/novel autoantibodies, where facilities to do so are available. *From: Harvey, G.R., MacFadyen, C. & Tansley, S.L. Newer Autoantibodies and Laboratory Assessments in Myositis. Curr Rheumatol Rep 27, 5 (2025).  🔗https://lnkd.in/dAneWCCv

Through collaboration with healthcare practitioners & patients, we've uncovered a major issue: slow & inefficient testing options in the world of gastrointestinal diagnostics. We're here to change that with Hydrogen/Methane Breath Testing that is convenient & highly accurate! 🌟 Discover more at allclearhealthcare.com ... #HealthcareInnovation #GutHealth #EfficientTesting #PatientCare

#DidYouKnow that when #BileAcids aren't properly reabsorbed in the intestines, excessive amounts can end up in your stool? Our Faecal Bile Acids Assay offers a reliable, non-invasive method for detecting bile acid diarrhoea. This test can support the differential diagnosis of chronic #diarrhoea, helping clinicians make informed decisions and offer targeted treatments. In turn, this can streamline the diagnostic process and improve patient outcomes. Find out more: https://ow.ly/VCm050TaKRm

Markus Zeitlinger was invited to talk about side effects and interactions concerning medication for CF (cystic fibrosis) during yesterdays event held by the "Mukoviszidose Help in Vienna, Lower Austria and Burgenland, Austria". Side effects and interactions are a very important topic, especially if someone is bound to taking several medications. At our clinic we have established a special unit focussing on this topic, so we were happy to share our expertise within the frame of this event. #CF #CongenitalMetabolicDisease #SideEffects #ClinicalPharmacology #Medication www.cystischefibrose.at

🌟 Exciting News! 🌟 Did you know that Cytosorb, our revolutionary blood purification technology, could potentially revolutionize the management of paraquat poisoning? Paraquat poisoning, resulting from exposure to the herbicide, induces severe inflammation and oxidative stress, often leading to multi-organ failure with dire consequences. However, Cytosorb offers a glimmer of hope by efficiently eliminating cytokines and inflammatory mediators from the bloodstream, potentially mitigating the systemic inflammatory response associated with paraquat poisoning. While further research is needed to confirm its efficacy definitively, Cytosorb emerges as a promising adjunctive therapy, potentially alleviating inflammation and oxidative stress, thereby bolstering organ function and improving patient outcomes. It's essential to remember that primary treatment for paraquat poisoning involves comprehensive supportive care, encompassing respiratory support and fluid management. In cases of suspected paraquat poisoning, swift medical attention is crucial, as early intervention can be life-saving. While Cytosorb presents exciting possibilities, its application remains experimental. Let's continue to explore innovative solutions for enhanced healthcare outcomes! 💪🔬 #Cytosorb #ParaquatPoisoning #HealthcareInnovation

Acute kidney injury (AKI) is a costly and dangerous risk for hospitals—and with no direct treatment available, patients and providers need a test that detects kidney stress before damage occurs, when intervention can still make a difference. Over the next nine weeks, we’re highlighting the assays of VIDAS®3 that are essential for diagnostic care, and today we’re excited to introduce you to VIDAS® NEPHROCHECK®—a rapid and reliable automated test that can identify patients at risk of moderate to severe AKI. Are you ready to transform your patient care? Discover VIDAS NEPHROCHECK and the full VIDAS 3 immunoassay menu today: bit.ly/vidas3

Chronic Venous Insufficiency Market Growth Anticipated by 2034 | Companies includes Verigraft, MediWound, TissueTech, Amniox Medical: Chronic Venous Insufficiency Market Several factors are expected to accelerate the growth of the Chronic Venous Insufficiency market during the forecast period (2023–2034). Increased awareness about available treatments, rising disease prevalence, and heightened disease awareness are key drivers. In the … Continue reading → #Business #Europe #HealthMedicine #PharmaceuticalsBiotech #US

📢The Cys-C Test Cassette is based on #Fluorescence Immunoassay to measure Cys-C in whole blood, serum or plasma to aid in the #diagnosis of #Renal function. By providing results through a Fluorescence Immunoassay Analyzer, this test facilitates timely detection of renal issues, expediting necessary #medical interventions. Combining swiftness with precision, it stands as a valuable tool for routine screening, early diagnosis and treatment tracking, thereby fostering improved patient #health. 🔎Learn more: https://lnkd.in/gfqy5j5c #RenalHealth #KidneyFunctionTest #FluorescenceImmunoassay #CysCTest #MedicalDiagnostics #HealthScreening #EarlyDiagnosis #PatientCare #InnovativeHealthcare #HealthcareSolutions #AllTest